Patents

US 12617838 B2: Auto/allo-immune defense receptors for the selective targeting of activated pathogenic T cells and NK cells

Granted
2026-05-05
Filed
2019-04-25 application 17049561
Type
Utility · 24 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Embodiments of the disclosure concern engineered auto/allo-immune defense receptor (ADR)-expressing T cells that selectively target activated T cells, including pathogenic T cells, to incapacitate them. The chimeric receptors comprise moieties for targeting 4-1BB, 0X40, and CD40L, for example, whose expression is indicative of activated T cells. In particular embodiments, there are methods of preventing or treating conditions associated with activated T cells using adoptive T-cell transfer of cells encoding the ADRs.

Source: PTBLXML, file of 2026-05-05 (ipgb20260505.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Baylor College of Medicine 276 patentsUS company or organizationHouston, TXBaylor College of Medicine College or university EXACT high confidence: identical full name and state
BAYLOR COLLEGE OF MEDICINE Nonprofit EXACT high confidence: identical full name and state
PTBLXML, file of 2026-05-05

Inventors

InventorPlacePatentsPerson pageSource
Maksim MamonkinHouston, TX3PTBLXML, file of 2026-05-05
Malcolm K. BrennerHouston, TX14PTBLXML, file of 2026-05-05
Feiyan MoHouston, TXPTBLXML, file of 2026-05-05

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K14/70578PTBLXML, file of 2026-05-05
A61KPreparations for medical, dental or toiletry purposesA61K40/11PTBLXML, file of 2026-05-05
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P37/06PTBLXML, file of 2026-05-05
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N5/0636PTBLXML, file of 2026-05-05

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2020-10-21Assignment
Assignment of assignor's interest
MAMONKIN, MAKSIM signed 2019-05-02
BRENNER, MALCOLM K. signed 2019-07-28
MO, FEIYAN signed 2019-05-03
BAYLOR COLLEGE OF MEDICINE HOUSTON, TX54132/19PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.